Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Efficacy”

52,067 trials

Showing 20 of 52,067 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07231523
What this trial is testing

EFG vs IVIG in TAMG

Who this might be right for
EfgartigimodIntravenous ImmunoglobulinMyasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital 64
Testing effectiveness (Phase 2)Study completedNCT02311582
What this trial is testing

MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma
Washington University School of Medicine 55
Early research (Phase 1)Temporarily pausedNCT06649682
What this trial is testing

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital 20
Not applicableStudy completedNCT05398159
What this trial is testing

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

Who this might be right for
Circumference Reduction of Abdomen
InMode MD Ltd. 75
Early research (Phase 1)UnknownNCT04448379
What this trial is testing

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc. 48
Large-scale testing (Phase 3)Study completedNCT04504396
What this trial is testing

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 620
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Large-scale testing (Phase 3)Active Not RecruitingNCT05063162
What this trial is testing

Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD)

Who this might be right for
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
UCB Biopharma SRL 113
Large-scale testing (Phase 3)Study completedNCT01063062
What this trial is testing

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT06656962
What this trial is testing

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

Who this might be right for
Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)
Renmin Hospital of Wuhan University 15
Post-approval studies (Phase 4)Study completedNCT02789488
What this trial is testing

Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome

Who this might be right for
Poly Cystic Ovary Syndrome
Chemical Resources 50
Testing effectiveness (Phase 2)Study completedNCT04181788
What this trial is testing

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

Who this might be right for
Advanced MalignanciesNon-small-cell Lung Cancer
Pfizer 155
Large-scale testing (Phase 3)Looking for participantsNCT07052903
What this trial is testing

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals 1,750
Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Early research (Phase 1)Study completedNCT03798561
What this trial is testing

Study to Evaluate ASN008 Topical Gel (TG)

Who this might be right for
Dermatitis, AtopicPruritusDermatitis Eczema
Asana BioSciences 24
Early research (Phase 1)Study completedNCT04925661
What this trial is testing

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

Who this might be right for
Chronic Kidney DiseasesRenal Anemia
Sunshine Lake Pharma Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Large-scale testing (Phase 3)Study completedNCT00051142
What this trial is testing

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Alcon Research
Large-scale testing (Phase 3)Study completedNCT00827242
What this trial is testing

Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily

Who this might be right for
Benign Prostatic Hyperplasia
Eli Lilly and Company 325
Not applicableUnknownNCT04500886
What this trial is testing

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome

Who this might be right for
Hemophagocytic Syndrome
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation